Azelis Group (ENXTBR:AZE) Valuation Check After Recent Share Price Momentum And Longer Term Drawdowns
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Recent share performance and business snapshot
Azelis Group (ENXTBR:AZE) has drawn fresh attention after recent share price moves, with the stock showing mixed returns across different periods and a current closing price of €10.68.
Over the past day the stock returned 0.95%, with a 0.57% return over the past week. The past month shows a 5.33% return, while the past 3 months reflect a 14.47% gain and the year to date return stands at 14.35%.
Looking over a longer horizon, the total return over the past year declined 27.40%, and over 3 years it declined 49.77%. These figures give you context for how recent strength compares with the longer term picture.
The company has an estimated market value of about €2.60b and focuses on distributing specialty chemicals and food ingredients across Europe, the Middle East and Africa, the Americas, and Asia Pacific.
See our latest analysis for Azelis Group.
The recent share price return, with a 5.33% move over 30 days and 14.47% over 3 months, contrasts with the declining 1 year and 3 year total shareholder returns. This suggests short term momentum has picked up while longer term investors are still facing significant drawdowns.
If you are weighing Azelis Group against other ideas, this can be a good moment to broaden your watchlist with 98 top founder-led companies
With Azelis Group trading at €10.68, alongside an indicated intrinsic discount and a gap to analyst targets, the key question is straightforward: is this an undervalued distributor of specialty chemicals, or has the market already priced in future growth?
Most Popular Narrative: 14.4% Undervalued
The most followed valuation narrative sees fair value at about €12.48 versus the current €10.68 share price, framing Azelis Group as undervalued on its own fundamentals.
Azelis Group's analyst fair value estimate has been trimmed from €13.20 to about €12.48. This reflects a reset in price targets after some analysts reduced their outlooks toward the mid-teens and low double digits, while still factoring in updated views on growth, margins and future P/E levels.
Curious what kind of revenue path, profit margins and future earnings multiple are baked into that fair value, and how they tie into analyst targets and discount rates.
Result: Fair Value of €12.48 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to weigh risks such as higher distribution and logistics costs squeezing margins, and weaker regions including China and Australia dragging on growth.
Find out about the key risks to this Azelis Group narrative.
Another angle on valuation
While the popular narrative frames Azelis Group as undervalued versus a fair value of €12.48, the current P/E of 23.4x tells a tougher story. It sits above both the European Trade Distributors average of 17.9x and the fair ratio of 22.2x, which raises the question of how much execution risk you are really being paid for.
To see how much weight to give that higher P/E compared with other valuation checks, it helps to walk through the full breakdown in one place, from cash flows to peer comparisons, in the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of recent momentum and longer term drawdowns, it pays to move quickly, review the full data set, and weigh both sides of the story yourself with 2 key rewards and 3 important warning signs
Looking for more investment ideas?
If you stop at one stock, you could miss better fits for your goals, so consider a few strong alternatives before you make your next move.
-
Target higher-quality value opportunities by scanning companies that currently look cheap on fundamentals using the 235 high quality undervalued stocks .
-
Strengthen your income stream by focusing on companies offering robust yields through the 460 dividend fortresses .
-
Reduce portfolio stress by concentrating on companies with sturdier financial profiles via the 304 resilient stocks with low risk scores .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AZE.BR .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
